Life Scientists Honored

Breakthrough Prizes of $3 million each go to five researchers in the life sciences, recognizing their pioneering work in optogenetics, disease-associated mutation analyses, and ancient DNA sequencing.

Written byKaren Zusi
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

STEVE JENNINGS/GETTY IMAGES (COURTESY BREAKTHROUGH PRIZE)The 2016 Breakthrough Prizes were awarded yesterday (November 8) in Silicon Valley. Pioneers in mathematics, physics, and the life sciences were honored with cash prizes during a ceremony for the award, which was cofounded by Facebook’s Mark Zuckerberg; his wife, Priscilla Chan; and Google cofounder Sergey Brin, among other tech titans.

“This year’s laureates have all opened up ways of understanding ourselves,” Anne Wojcicki, a Breakthrough Prize cofounder and chief executive of the personal genomics company 23andMe, said in a press release. “In the life sciences, they have pushed forward new ideas about Alzheimer’s, cholesterol, neurological imaging, and the origins of our species. And for that we celebrate them.”

Edward Boyden of MIT and Karl Deisseroth of Stanford University were each awarded prizes for their work on optogenetics, which allows researchers to program neurons to activate when exposed to a pulse of light. (See Boyden’s feature, “The Birth of Optogenetics,” The Scientist, July 2011.)

“Optogenetics’ biggest impact by far has been in enabling thousands of discoveries about how neural circuits control behavior,” Deisseroth said in a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies